The silencing of FAM83A can inhibit the proliferation, invasion and migration of lung cancer cells, which may be related to the inhibition of epidermal growth factor receptor (EGFR)/mitogen activated protein kinase (MAPK)/choline kinase α (CHKA) signal transduction and activation. Here, EGFR is linked to lung cancer.